Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathological Changes of Tau Related to Alzheimer’s Disease
Dandan Chu, Fei Liu
ACS Chemical Neuroscience (2018) Vol. 10, Iss. 2, pp. 931-944
Closed Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Role of tau protein in Alzheimer's disease: The prime pathological player
Shibi Muralidar, Senthil Visaga Ambi, Saravanan Sekaran, et al.
International Journal of Biological Macromolecules (2020) Vol. 163, pp. 1599-1617
Closed Access | Times Cited: 170
Amyloid-type Protein Aggregation and Prion-like Properties of Amyloids
Dieter Willbold, Birgit Strodel, Gunnar F. Schröder, et al.
Chemical Reviews (2021) Vol. 121, Iss. 13, pp. 8285-8307
Open Access | Times Cited: 148
Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis
Hongmei Li, Chia‐Chen Liu, Hui Zheng, et al.
Translational Neurodegeneration (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 90
Role of dietary fatty acids in microglial polarization in Alzheimer’s disease
Smita Eknath Desale, Subashchandrabose Chinnathambi
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 83
Truncation of Tau selectively facilitates its pathological activities
Jianlan Gu, Wen Xu, Nana Jin, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 40, pp. 13812-13828
Open Access | Times Cited: 70
Lysine 63-linked ubiquitination of tau oligomers contributes to the pathogenesis of Alzheimer’s disease
Nicha Puangmalai, Urmi Sengupta, Nemil Bhatt, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 4, pp. 101766-101766
Open Access | Times Cited: 43
The Role of Post-Translational Modifications on the Structure and Function of Tau Protein
Haiqiong Ye, Yue Han, Ping Li, et al.
Journal of Molecular Neuroscience (2022) Vol. 72, Iss. 8, pp. 1557-1571
Closed Access | Times Cited: 41
Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies
Kendall B. E. Moore, Ta-Jung Hung, Jessica S. Fortin
Drug Discovery Today (2023) Vol. 28, Iss. 3, pp. 103487-103487
Open Access | Times Cited: 36
Role of Tau Protein in Neurodegenerative Diseases and Development of Its Targeted Drugs: A Literature Review
J Yang, Weijia Zhi, Lifeng Wang
Molecules (2024) Vol. 29, Iss. 12, pp. 2812-2812
Open Access | Times Cited: 11
Freestanding Nanofiber‐Assembled Aptasensor for Precisely and Ultrafast Electrochemical Detection of Alzheimer's Disease Biomarkers
Hui Liu, Xueli Yuan, Tao Liu, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 15
Open Access | Times Cited: 7
Insights into Disease-Associated Tau Impact on Mitochondria
Leonora Szabo, Anne Eckert, Amandine Grimm
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6344-6344
Open Access | Times Cited: 66
A mechanistic survey of Alzheimer's disease
Yijing Tang, Dong Zhang, Xiong Gong, et al.
Biophysical Chemistry (2021) Vol. 281, pp. 106735-106735
Open Access | Times Cited: 45
Biomarkers associated with the pathogenesis of Alzheimer’s disease
Hui Wang, Mengli Sun, Wenhui Li, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 15
Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy
Emma Ortiz, Pedro Montes, Citlali Ekaterina Rodríguez-Pérez, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 128-128
Open Access
Review of Alzheimer’s disease drugs and their relationship with neuron-glia interaction
Michael Kunle Ajenikoko, Abayomi Oyeyemi Ajagbe͓, Oluwanisola Onigbinde, et al.
IBRO Neuroscience Reports (2022) Vol. 14, pp. 64-76
Open Access | Times Cited: 26
Design of a selective and water-soluble fluorescent probe targeting Tau fibrils for intracellular and in vivo imaging
Liang Ji, Xinguang Zhou, Runduo Liu, et al.
Sensors and Actuators B Chemical (2023) Vol. 380, pp. 133415-133415
Closed Access | Times Cited: 14
Iron and Targeted Iron Therapy in Alzheimer’s Disease
Jian Wang, Jiaying Fu, Yuanxin Zhao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16353-16353
Open Access | Times Cited: 13
The complex effects of miR-146a in the pathogenesis of Alzheimer’s disease
Yunfan Long, Jiajia Liu, Yu Wang, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 5, pp. 1309-1323
Open Access | Times Cited: 4
Novel Multitarget Directed Triazinoindole Derivatives as Anti-Alzheimer Agents
Dushyant V. Patel, Nirav R. Patel, Ashish M. Kanhed, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 8, pp. 3635-3661
Closed Access | Times Cited: 36
Oxidative distress in aging and age-related diseases: Spatiotemporal dysregulation of protein oxidation and degradation
S. P. Zavadskiy, Susanna S. Sologova, Nurbubu T. Moldogazieva
Biochimie (2021) Vol. 195, pp. 114-134
Closed Access | Times Cited: 29
Lactobacillaceae improve cognitive dysfunction via regulating gut microbiota and suppressing Aβ deposits and neuroinflammation in APP/PS1 mice
Yusong Wu, Xiaohui Niu, Peifan Li, et al.
Archives of Microbiology (2023) Vol. 205, Iss. 4
Closed Access | Times Cited: 9
1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer’s Signaling in Human Nerve Cells
Zhibin Liang, Bei Zhang, Meng Xu, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 9, pp. 4018-4030
Open Access | Times Cited: 29
Usnic acid derivatives as tau-aggregation and neuroinflammation inhibitors
Cunjian Shi, Peng Wan, Jinhua Zhao, et al.
European Journal of Medicinal Chemistry (2019) Vol. 187, pp. 111961-111961
Closed Access | Times Cited: 27
Tau truncation in the pathogenesis of Alzheimer’s disease: a narrative review
Dandan Chu, Xingyue Yang, Jing Wang, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 6, pp. 1221-1232
Open Access | Times Cited: 8
Exploring Tau Fibril-Disaggregating and Antioxidating Molecules Binding to Membrane-Bound Amyloid Oligomers Using Machine Learning-Enhanced Docking and Molecular Dynamics
Luthary Segura, Natália Quevedo dos Santos, Rafael Flores, et al.
Molecules (2024) Vol. 29, Iss. 12, pp. 2818-2818
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top